Health In Tech, Inc. (Nasdaq: HIT) announced the appointment of Christina R. Valauri to its Board of Directors as an independent director, effective November 12, 2026. Ms. Valauri brings more than 30 years of financial services leadership and corporate governance experience, having held senior executive positions at Cantor Fitzgerald, Natixis, ING Barings, and Crédit Lyonnais.

The filing details that Ms. Valauri will serve on the Board’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. She is a recognized healthcare investment research professional who was ranked No. 1 in the biomedical and biotechnology sector in The Wall Street Journal’s “Best on the Street” All-Star Analyst Survey. Her career includes over 16 years as a senior sell-side equity research analyst covering pharmaceutical, biotechnology, and medical technology companies.

In addition to Ms. Valauri, the Company reported the election of Tim Cortes, age 60, to the Board, effective November 10, 2026. The Board also appointed Chief Executive Officer Sanjay Shrestha, age 52, to the Board, effective November 12, 2026. Mr. Cortes was appointed as an independent director to the Audit Committee, the Nominating and Corporate Governance Committee, and as Chair of the Compensation Committee.

The filing notes that Mr. Cortes and Ms. Valauri will each serve a one-year term. Effective upon their respective appointments, they became eligible to receive compensation in accordance with the Company’s non-employee director compensation policy. The Company intends to enter into indemnification agreements with both Mr. Cortes and Ms. Valauri in the same form as agreements entered into with other directors and officers.

Ms. Valauri currently serves as an independent director of two other Nasdaq-listed companies, Valion Bio, Inc. (Nasdaq: VBIO) since July 2024 and Precipio, Inc. (Nasdaq: PRPO) since January 2024. She is also the Founder and CEO of Sagestone Advisory LLC and serves as a Mentor and Guest Lecturer at Weill Cornell Medicine’s BioVenture eLab.